Li, Eric V. http://orcid.org/0000-0002-5506-5755
Busza, Anna M.
Siddiqui, Mohammad R. http://orcid.org/0000-0001-8196-5864
Aguiar, Jonathan A. http://orcid.org/0000-0001-5418-419X
Keeter, Mary-Kate
Neill, Clayton
Kumar, Sai K. http://orcid.org/0000-0002-3577-3543
Mi, Xinlei
Schaeffer, Edward M. http://orcid.org/0000-0003-0699-1899
Patel, Hiten D.
Ross, Ashley E. http://orcid.org/0000-0001-7044-9688
Article History
Received: 17 April 2024
Revised: 17 May 2024
Accepted: 23 May 2024
First Online: 10 June 2024
Competing interests
: AER is engaged in consulting with American Society of Clinical Oncology (ASCO), Astellas, Bayer HealthCare Pharmaceuticals, Blue Earth Diagnostics, Janssen Biotech, Lantheus Medical Imaging, Myovant Sciences, NCCN, Pfizer, Tempus Health, and Veracyte. EMS is engaged in consulting with Astellas, Lantheus Medical Imaging, Pfizer. • The other contributing authors have no conflicts of interest to declare.
: The study was reviewed under IRB STU00211144 issued by Northwestern University. The study was performed in accordance with the Declaration of Helsinki.